These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19194624)

  • 1. [Pilot study: tobacco-attributable direct costs in two hospitals in Santiago, Chile].
    Martínez-Gutiérrez MS; Vanegas L J; Reveco U S; Valenzuela R R; Arteaga H O
    Rev Med Chil; 2008 Oct; 136(10):1281-7. PubMed ID: 19194624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing medical expenditures on 4 smoking-related diseases, 1996-2001.
    Kahende JW; Woollery TA; Lee CW
    Am J Health Behav; 2007; 31(6):602-11. PubMed ID: 17691873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economic burden of smoking-related disease in Thailand: a prevalence-based analysis.
    Leartsakulpanitch J; Nganthavee W; Salole E
    J Med Assoc Thai; 2007 Sep; 90(9):1925-9. PubMed ID: 17957939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Morbidity, mortality and the potential years of life lost attributable to tobacco].
    Rodríguez Tapioles R; Bueno Cavanillas A; Pueyos Sánchez A; Espigares García M; Martínez González MA; Gálvez Vargas R
    Med Clin (Barc); 1997 Feb; 108(4):121-7. PubMed ID: 9162780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking-related diseases: the importance of COPD.
    Zaher C; Halbert R; Dubois R; George D; Nonikov D
    Int J Tuberc Lung Dis; 2004 Dec; 8(12):1423-8. PubMed ID: 15636487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annual smoking-attributable mortality, years of potential life lost, and economic costs--United States, 1995-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Apr; 51(14):300-3. PubMed ID: 12002168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence-based, disease-specific estimate of the social cost of smoking in Singapore.
    Cher BP; Chen C; Yoong J
    BMJ Open; 2017 Apr; 7(4):e014377. PubMed ID: 28389491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Active tobacco smoking as determinant of costs of inpatient treatment of COPD exacerbations].
    Targowski T; Jahnz-Rózyk K; From S; Płusa T
    Przegl Lek; 2004; 61(10):1049-51. PubMed ID: 15794248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Smoking and lung cancer: attributable risks according to gender].
    Erazo B M; Amigo C H; Oyarzún G M; Peruga U A
    Rev Med Chil; 2008 Oct; 136(10):1272-80. PubMed ID: 19194623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The costs of smoking in Vietnam: the case of inpatient care.
    Ross H; Trung DV; Phu VX
    Tob Control; 2007 Dec; 16(6):405-9. PubMed ID: 18048618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between disease severity, smoking index age and direct costs of hospital treatment of COPD exacerbations].
    Targowski T; Jahnz-Rózyk K; From S; Płusa T
    Pneumonol Alergol Pol; 2005; 73(1):32-5. PubMed ID: 16539181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Walk-in spirometry pilot project for discovering of early chronic obstructive pulmonary disease].
    Løkke A; Christensen LB; Fuglsang C
    Ugeskr Laeger; 2009 Oct; 171(43):3083-8. PubMed ID: 19852895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economics of COPD: literature review and experiences from field work.
    Nielsen R; Klemmetsby M; Gulsvik A
    Clin Respir J; 2008 Oct; 2 Suppl 1():104-10. PubMed ID: 20298358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking-attributable mortality--Mexico, 1992.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1995 May; 44(19):372-3, 379-81. PubMed ID: 7739511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global perspective on tobacco control. Part I. The global state of the tobacco epidemic.
    Slama K
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):3-7. PubMed ID: 18173869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modelling of the costs of productivity losses due to smoking in Germany for the year 2005].
    Prenzler A; Mittendorf T; von der Schulenburg JM
    Gesundheitswesen; 2007 Nov; 69(11):635-43. PubMed ID: 18080936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The carcinogenic and toxic effects of tobacco smoke: are women particularly susceptible?
    Pope M; Ashley MJ; Ferrence R
    J Gend Specif Med; 1999; 2(6):45-51. PubMed ID: 11279871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smooth quantile ratio estimation with regression: estimating medical expenditures for smoking-attributable diseases.
    Dominici F; Zeger SL
    Biostatistics; 2005 Oct; 6(4):505-19. PubMed ID: 15872022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K; Targowski T; From S
    Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.